Company: HURA
Filing Date: 2025-11-14
Form Type: 10-Q
Source: 0001193125-25-281539
Chunk: 1

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-11-14
Form: 10-Q
Item: Item 1
Chunk 1
---
75,000,000 shares authorized; 51,254,789 and 42,323,759 shares issued and outstanding as of September 30, 2025 and December 31, 2024.

     51,255

     42,324

     Additional paid in capital

     150,869,671

     125,397,691

     Accumulated deficit

     (134,421,497
     )

     (111,124,569
     )

     Total Stockholders’ Equity

     16,777,959

     14,593,976

     Total Liabilities and Stockholders' Equity
      
     $
     25,697,048

     $
     19,966,684

The accompanying notes are an integral part of these condensed consolidated financial statements.